Arbe Robotics Prices $15M Offering at $0.60, Shares Slip 5.5%

Arbe Robotics Ltd. (NASDAQ: ARBE) priced an underwritten registered direct offering worth roughly $15 million on Sept. 25, 2026, the company announced. The deal splits into 833,334 ordinary shares at $0.60 each and pre-funded warrants for up to 24,166,666 ordinary shares priced at $0.5999, equal to the share price minus the $0.0001 warrant exercise price. ARBE traded at $0.6350 as of 23:29 UTC today, down 5.51%, within a session range of $0.6001 to $0.6480, according to live market data.

Context — why this matters now

The structure of this offering is the headline, not just its size. Only 833,334 ordinary shares are being sold outright; the bulk of the raise rides on pre-funded warrants covering up to 24,166,666 shares. Those warrants are immediately exercisable and do not expire until exercised in full, the company said. That mechanic lets certain investors pay nearly the full share price upfront while deferring the formal share issuance.

Arbe said it intends to use net proceeds for working capital and general corporate purposes. The company specifically cited scaling operations to support growing commercial opportunities, including its recently announced selection for an L3 passenger vehicle program at what it called one of the world's largest automotive groups. It also flagged intended expansion into defense and counter-drone markets, plus the potential pursuit of strategic merger and acquisition opportunities.

That list matters because it frames the raise as growth capital rather than emergency liquidity. The company did not disclose current cash balances, burn rate, or how many months of runway the $15 million represents. It also did not state whether any existing holders participated or whether the offering was oversubscribed.

One detail a reader would expect is conspicuously absent: the company gave no comparison to a prior financing round, no reference price from an earlier raise, and no update on its share count before or after the deal. The report offers no prior-period benchmark, so the magnitude of dilution relative to earlier capital raises cannot be calculated from the disclosed figures alone.

The timing carries its own context. Arbe's forward-looking risk language includes the possibility of delisting from Nasdaq if its bid price stays below $1.00, alongside the effect of hostilities in Israel and the call-up of a significant portion of its working population. The company also referenced its ability to develop and market the Alerion radar system and deliver units in a timely and profitable manner. A sub-$1.00 share price sits directly against that delisting threshold, and this offering prices new shares below the current market level.

Data — what the numbers show

The arithmetic of the raise is straightforward. Gross proceeds land at approximately $15 million before underwriting discounts, commissions, and other offering expenses. The company did not disclose the size of those discounts or the net figure it expects to receive.

Component	Terms
Ordinary shares offered	833,334
Ordinary share price	$0.60
Pre-funded warrants	Up to 24,166,666 shares
Warrant price	$0.5999
Warrant exercise price	$0.0001
Gross proceeds	~$15 million

The share price of $0.60 sits below the live market quote. ARBE traded at $0.6350 as of 23:29 UTC today, and the session low of $0.6001 essentially touched the offering price. The session high of $0.6480 shows the stock spent part of the day above both the offering price and the closing quote.

That gap between the $0.60 offer price and the $0.6350 market price tells investors the deal was priced at a discount to where the stock was trading. The 5.51% decline on the day reflects that spread being absorbed by the market.

For scale, the combined share and warrant coverage of up to roughly 25 million ordinary shares is many multiples of the 833,334 shares sold outright. The report does not give the company's total shares outstanding, so the precise percentage of dilution cannot be computed from the disclosed figures. No peer comparison is available in the report or the market data provided.

Canaccord Genuity is acting as sole bookrunner. The offering is being made under a Form F-3 registration statement (File No. 333-287805), originally filed June 5, 2025, and declared effective by the SEC on June 13, 2025. The deal is expected to close on or about Sept. 28, 2026, subject to customary closing conditions.

Analysis — what it means for markets and sectors

The pre-funded warrant structure is the piece that changes the read on this deal. Because the warrants are immediately exercisable and never expire, they function as a deferred share issuance. Investors get economic exposure now while the company avoids booking the full share count at signing. When exercised, those shares enter the float, and the overhang persists until the warrants are fully converted.

For a company whose risk factors explicitly name a possible Nasdaq delisting if the bid stays below $1.00, issuing equity at $0.60 is a double-edged move. It brings in capital the company says it needs for commercial scaling and defense expansion. It also adds potential share supply at a price below the delisting threshold, which is the same zone where the stock is currently trading.

The defense and counter-drone expansion Arbe named is a live sector theme, but the report gives no contract values, customer names beyond the L3 passenger vehicle program, or revenue timelines. Investors cannot size the opportunity from this disclosure. The merger and acquisition language is similarly open-ended, described as a potential use of proceeds rather than a committed plan.

A fair counter-argument: a $15 million raise is small for a company pursuing automotive and defense scaling. Development cycles in those markets are long and capital-intensive, and the company did not specify how far this sum extends its runway. That limits how much this financing can be read as a de-risking event.

Positioning-wise, the flow is straightforward. New investors are taking shares and warrants at $0.60 and $0.5999. Existing holders absorb dilution, and the 5.51% decline suggests the market repriced for it. The stock's session range shows buyers stepping in near the offering price at the low end.

Outlook — what to watch next

The near-term catalyst is the expected closing on or about Sept. 28, 2026, subject to customary conditions. A delay or failure to close would be a meaningful signal, though the company gave no indication either is expected.

The final prospectus supplement filing with the SEC is the next disclosure event. That document should carry the net proceeds figure and the underwriting discount that this announcement leaves out. It may also quantify the share count after the deal.

On the operating side, watch for any update on the L3 passenger vehicle program Arbe cited, and any concrete defense or counter-drone contract announcements. Both were named as reasons for the raise, but neither came with figures here. The company's next quarterly filing would be the natural venue for a cash position update, and no date for that is given in the report.

Frequently Asked Questions

What does a pre-funded warrant mean for Arbe shareholders?

A pre-funded warrant lets an investor pay almost the full share price now but receive shares later upon exercise, in this case at $0.0001 per share. Arbe's warrants are immediately exercisable and do not expire until fully exercised. For existing holders, the practical effect is potential future share issuance of up to 24,166,666 shares entering the float when exercised, separate from the 833,334 shares sold outright.